(AMSC) American Superconductor - Overview
Stock: Gridtec, Windtec, D-VAR, ActiVAR, ArmorVAR
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 70.8% |
| Relative Tail Risk | -11.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.43 |
| Alpha | -23.84 |
| Character TTM | |
|---|---|
| Beta | 2.262 |
| Beta Downside | 2.170 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.86% |
| CAGR/Max DD | 1.03 |
Description: AMSC American Superconductor January 13, 2026
American Superconductor Corp. (NASDAQ: AMSC) delivers megawatt-scale power-resiliency solutions through two operating segments – Grid and Wind – under the Gridtec Solutions and Windtec Solutions brands.
The Grid segment supplies utilities and industrial customers with transmission-planning services, D-VAR and actiVAR reactive-compensation hardware, and ship-protection systems. Its product mix targets congestion mitigation, voltage control, and power-quality improvement for both AC transmission networks and naval platforms.
The Wind segment licenses high-power (≥ 2 MW) turbine drivetrain designs and provides associated power-electronics, software control, and engineering support to turbine manufacturers worldwide.
Key market drivers include the U.S. Infrastructure Investment and Jobs Act, which earmarks roughly $65 billion for grid modernization, and the accelerating global renewable-energy build-out (≈ 12 % YoY new capacity in 2023). These trends underpin demand for AMSC’s voltage-control and grid-integration technologies.
Recent financial metrics (FY 2023) show a $70 million revenue base with a + 15 % year-over-year increase in backlog, reflecting growing orders for D-VAR systems in North America. The company’s gross margin has hovered around 30 %, but remains sensitive to the timing of large utility contracts.
Given the capital-intensive nature of grid upgrades and the competitive landscape (e.g., Siemens, ABB), AMSC’s upside hinges on winning multi-year utility contracts and expanding its Windtec licensing footprint in emerging markets.
For a deeper quantitative view, you may find ValueRay’s AMSC dashboard useful.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 15.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.85 > 1.0 |
| NWC/Revenue: 95.79% < 20% (prev 56.77%; Δ 39.02% < -1%) |
| CFO/TA 0.05 > 3% & CFO 22.8m > Net Income 15.1m |
| Net Debt (-212.1m) to EBITDA (19.8m): -10.69 < 3 |
| Current Ratio: 3.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (44.2m) vs 12m ago 17.90% < -2% |
| Gross Margin: 29.65% > 18% (prev 0.27%; Δ 2937 % > 0.5%) |
| Asset Turnover: 71.58% > 50% (prev 59.02%; Δ 12.56% > 0%) |
| Interest Coverage Ratio: -4.34 > 6 (EBITDA TTM 19.8m / Interest Expense TTM -3.11m) |
Altman Z'' -14.31
| A: 0.57 (Total Current Assets 342.9m - Total Current Liabilities 87.8m) / Total Assets 445.6m |
| B: -2.35 (Retained Earnings -1.05b / Total Assets 445.6m) |
| C: 0.04 (EBIT TTM 13.5m / Avg Total Assets 372.0m) |
| D: -10.13 (Book Value of Equity -1.05b / Total Liabilities 103.4m) |
| Altman-Z'' Score: -14.31 = D |
Beneish M -3.23
| DSRI: 0.66 (Receivables 39.9m/40.1m, Revenue 266.3m/176.1m) |
| GMI: 0.92 (GM 29.65% / 27.39%) |
| AQI: 0.66 (AQ_t 0.13 / AQ_t-1 0.20) |
| SGI: 1.51 (Revenue 266.3m / 176.1m) |
| TATA: -0.02 (NI 15.1m - CFO 22.8m) / TA 445.6m) |
| Beneish M-Score: -3.23 (Cap -4..+1) = AA |
What is the price of AMSC shares?
Over the past week, the price has changed by -17.49%, over one month by -21.86%, over three months by -56.33% and over the past year by +1.68%.
Is AMSC a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AMSC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 61 | 135.1% |
| Analysts Target Price | 61 | 135.1% |
| ValueRay Target Price | 33.6 | 29.4% |
AMSC Fundamental Data Overview February 03, 2026
P/E Forward = 26.9542
P/S = 5.349
P/B = 4.161
P/EG = -0.06
Revenue TTM = 266.3m USD
EBIT TTM = 13.5m USD
EBITDA TTM = 19.8m USD
Long Term Debt = 3.65m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 968.0k USD (from shortTermDebt, last quarter)
Debt = 3.65m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -212.1m USD (from netDebt column, last quarter)
Enterprise Value = 1.21b USD (1.42b + Debt 3.65m - CCE 215.8m)
Interest Coverage Ratio = -4.34 (Ebit TTM 13.5m / Interest Expense TTM -3.11m)
EV/FCF = 63.78x (Enterprise Value 1.21b / FCF TTM 19.0m)
FCF Yield = 1.57% (FCF TTM 19.0m / Enterprise Value 1.21b)
FCF Margin = 7.14% (FCF TTM 19.0m / Revenue TTM 266.3m)
Net Margin = 5.69% (Net Income TTM 15.1m / Revenue TTM 266.3m)
Gross Margin = 29.65% ((Revenue TTM 266.3m - Cost of Revenue TTM 187.3m) / Revenue TTM)
Gross Margin QoQ = 31.03% (prev 33.84%)
Tobins Q-Ratio = 2.72 (Enterprise Value 1.21b / Total Assets 445.6m)
Interest Expense / Debt = 4.77% (Interest Expense 174.0k / Debt 3.65m)
Taxrate = 2.40% (117.0k / 4.87m)
NOPAT = 13.2m (EBIT 13.5m * (1 - 2.40%))
Current Ratio = 3.90 (Total Current Assets 342.9m / Total Current Liabilities 87.8m)
Debt / Equity = 0.01 (Debt 3.65m / totalStockholderEquity, last quarter 342.2m)
Debt / EBITDA = -10.69 (Net Debt -212.1m / EBITDA 19.8m)
Debt / FCF = -11.16 (Net Debt -212.1m / FCF TTM 19.0m)
Total Stockholder Equity = 266.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.07% (Net Income 15.1m / Total Assets 445.6m)
RoE = 5.69% (Net Income TTM 15.1m / Total Stockholder Equity 266.3m)
RoCE = 4.99% (EBIT 13.5m / Capital Employed (Equity 266.3m + L.T.Debt 3.65m))
RoIC = 4.94% (NOPAT 13.2m / Invested Capital 266.3m)
WACC = 14.23% (E(1.42b)/V(1.43b) * Re(14.25%) + D(3.65m)/V(1.43b) * Rd(4.77%) * (1-Tc(0.02)))
Discount Rate = 14.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 23.27%
[DCF Debug] Terminal Value 55.15% ; FCFF base≈18.7m ; Y1≈16.1m ; Y5≈12.6m
Fair Price DCF = 6.70 (EV 106.9m - Net Debt -212.1m = Equity 319.0m / Shares 47.6m; r=14.23% [WACC]; 5y FCF grow -16.97% → 2.90% )
EPS Correlation: 83.76 | EPS CAGR: 25.50% | SUE: -2.20 | # QB: 0
Revenue Correlation: 94.71 | Revenue CAGR: 27.10% | SUE: -0.71 | # QB: 0
EPS next Year (2027-03-31): EPS=1.11 | Chg30d=+0.040 | Revisions Net=+1 | Growth EPS=+32.8% | Growth Revenue=+24.5%